Chemical activators of Nkx-2.3 can function through various signaling pathways to induce its activity within cells. Dibutyryl cyclic AMP (db-cAMP) and Forskolin elevate intracellular cAMP levels, which in turn activate protein kinase A (PKA). The activated PKA can then phosphorylate proteins that interact with Nkx-2.3, leading to its activation. Similarly, 8-Bromo-cAMP acts as a cAMP analog, further enhancing the PKA pathway and culminating in the phosphorylation of proteins that could activate Nkx-2.3. Isoproterenol, functioning as a beta-adrenergic agonist, also raises cAMP levels, thereby stimulating PKA, which can then target and activate Nkx-2.3. On another front, Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which might phosphorylate intermediary proteins to influence the activity of Nkx-2.3. In a similar vein, Staurosporine, though primarily a PKC inhibitor, at low concentrations can non-specifically activate other kinases that may result in the phosphorylation and subsequent activation of Nkx-2.3.
Calcium ionophores like Ionomycin and A-23187 (Calcimycin) elevate intracellular calcium levels, which activate calcium-dependent kinases capable of phosphorylating proteins that regulate Nkx-2.3, leading to its activation. Likewise, Bay K8644, by acting as an L-type calcium channel agonist, can increase calcium influx and subsequently activate calcium-dependent kinases that may phosphorylate and activate Nkx-2.3. In the realm of kinase modulation, Okadaic acid inhibits protein phosphatases PP1 and PP2A, causing an increase in phosphorylation levels within the cell, hindering the dephosphorylation of proteins involved in the activation of Nkx-2.3. Anisomycin, through its activation of the JNK pathway, can lead to the phosphorylation of transcription factors and associated proteins, which in turn may activate Nkx-2.3. Finally, Epidermal Growth Factor (EGF) stimulates the EGFR pathway, leading to MAPK/ERK signaling, which can phosphorylate proteins that directly interact with and activate Nkx-2.3, facilitating its role in transcriptional regulation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP is a cell-permeable analog of cAMP. Since Nkx-2.3 is a transcription factor that can be regulated by PKA, which is activated by cAMP, db-cAMP can elevate PKA activity, leading to phosphorylation events that may activate Nkx-2.3. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly activates adenylate cyclase, increasing intracellular levels of cAMP, which in turn activates PKA. PKA can phosphorylate substrates that could include proteins interacting with or regulating the activity of Nkx-2.3, leading to its functional activation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is an activator of protein kinase C (PKC). PKC can phosphorylate intermediary proteins that may influence the activity of Nkx-2.3 by altering its conformation or interaction with other proteins. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore, elevating intracellular calcium levels, which can activate calcium-dependent protein kinases that may in turn phosphorylate and activate Nkx-2.3. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcimycin is another calcium ionophore that elevates intracellular calcium and activates calcium-dependent kinases. These kinases could phosphorylate Nkx-2.3 or associated regulatory proteins, leading to the activation of Nkx-2.3. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that can increase cAMP levels via G protein-coupled receptor signaling, subsequently activating PKA, which could then activate Nkx-2.3 through phosphorylation. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cAMP analog that activates PKA. PKA activation can result in phosphorylation of proteins that regulate Nkx-2.3, leading to its activation. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is an inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels within the cell. This could result in the activation of Nkx-2.3 due to reduced dephosphorylation rates of proteins that control its activity. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a JNK activator, and JNK signaling can lead to the activation of transcription factors through phosphorylation. It could activate Nkx-2.3 by phosphorylating proteins that modulate its activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent PKC inhibitor but can act non-specifically to activate other kinases at lower concentrations. This non-specific kinase activation may lead to phosphorylation and activation of Nkx-2.3. | ||||||